{"id":699750,"date":"2026-06-25T05:56:03","date_gmt":"2026-06-25T05:56:03","guid":{"rendered":"https:\/\/microscopemedia.com\/?p=699750"},"modified":"2026-06-25T05:56:03","modified_gmt":"2026-06-25T05:56:03","slug":"oms-va-incepe-saptamana-viitoare-studii-clinice-cu-doua-medicamente-pentru-ebola-in-congo","status":"publish","type":"post","link":"https:\/\/microscopemedia.com\/?p=699750","title":{"rendered":"OMS va \u00eencepe s\u0103pt\u0103m\u00e2na viitoare studii clinice cu dou\u0103 medicamente pentru Ebola \u00een Congo"},"content":{"rendered":"<div><img decoding=\"async\" src=\"https:\/\/microscopemedia.com\/wp-content\/uploads\/2026\/06\/oms-va-incepe-saptamana-viitoare-studii-clinice-cu-doua-medicamente-pentru-ebola-in-congo.jpg\" class=\"ff-og-image-inserted\"><\/div>\n<p id=\"p-0\">La o conferin\u021b\u0103 de pres\u0103 la Geneva, directorul general al OMS, Tedros Adhanom Ghebreyesus, a declarat c\u0103 preg\u0103tirile pentru studiu au fost finalizate. \u00cen cadrul studiului, se va evalua dac\u0103 antiviralele MBP134 \u0219i Remdesivir pot reduce mortalitatea \u00een r\u00e2ndul pacien\u021bilor cu boala cu virus Bundibugyo, fie singure, fie \u00een combina\u021bie.<\/p>\n<p id=\"p-1\">Tedros a mul\u021bumit SUA \u0219i Gilead Sciences pentru donarea de doze pentru studiu, ad\u0103ug\u00e2nd c\u0103 mai multe detalii vor fi anun\u021bate s\u0103pt\u0103m\u00e2na viitoare, scrie <strong><a href=\"https:\/\/www.aa.com.tr\/en\/health\/who-to-begin-trial-of-2-ebola-therapeutics-in-congo-next-week\/3976974\" target=\"_blank\" rel=\"noopener\">Anadolu<\/a><\/strong>.<\/p>\n<p id=\"p-2\">Studiul va fi condus de un consor\u021biu care include Institutul Na\u021bional de Cercetare Biomedical\u0103 din Congo, ALIMA, Universitatea Oxford \u0219i OMS.<\/p>\n<h2 id=\"chapter-0\">Starea medicului francez<\/h2>\n<p id=\"p-3\">Anun\u021bul a venit \u00een momentul \u00een care Fran\u021ba a raportat primul s\u0103u caz confirmat de Ebola, care implic\u0103 un medic \u00eentors dintr-o misiune \u00een Congo dup\u0103 ce a \u00eengrijit un pacient cu Ebola \u00een timp ce lucra cu organiza\u021bia de ajutor ALIMA.<\/p>\n<p id=\"p-4\">\u201ePacientul se descurc\u0103 bine, are simptome u\u0219oare \u0219i febr\u0103\u201d, a declarat reporterilor Abdirahman Mahamud, directorul OMS pentru opera\u021biuni de alert\u0103 \u0219i r\u0103spuns \u00een situa\u021bii de urgen\u021b\u0103.<\/p>\n<p id=\"p-5\">Mahamud a spus c\u0103 autorit\u0103\u021bile franceze au ac\u021bionat rapid pentru a identifica \u0219i izola cazul \u0219i c\u0103 evaluarea de c\u0103tre OMS a riscului pentru Fran\u021ba \u0219i popula\u021bia global\u0103 \u201er\u0103m\u00e2ne sc\u0103zut\u0103\u201d.<\/p>\n<p id=\"p-6\">Autorit\u0103\u021bile sanitare franceze au declarat c\u0103 este \u00een curs de desf\u0103\u0219urare o investiga\u021bie epidemiologic\u0103 complet\u0103 pentru a identifica persoanele care ar fi putut fi \u00een contact cu pacientul.<\/p>\n<p id=\"p-7\">Cei identifica\u021bi vor fi contacta\u021bi de agen\u021bia regional\u0103 de s\u0103n\u0103tate, plasa\u021bi 21 de zile \u00een izolare la domiciliu \u0219i monitoriza\u021bi \u00eendeaproape \u00een aceast\u0103 perioad\u0103.<\/p>\n<h2 id=\"chapter-1\">Acum: 1.094 de cazuri confirmate de Ebola \u0219i 277 de decese \u00een Congo<\/h2>\n<p id=\"p-8\">Tedros a spus c\u0103 acest caz serve\u0219te ca un memento al riscurilor cu care se confrunt\u0103 responden\u021bii din prima linie, men\u021bion\u00e2nd c\u0103 aproape 80 de lucr\u0103tori din domeniul s\u0103n\u0103t\u0103\u021bii au fost infecta\u021bi \u00een focar.<\/p>\n<p id=\"p-9\">Potrivit OMS, acum exist\u0103 1.094 de cazuri confirmate de Ebola \u0219i 277 de decese \u00een Congo.<\/p>\n<p id=\"p-10\">De c\u00e2nd focarul a fost raportat, acum cinci s\u0103pt\u0103m\u00e2ni, capacitatea de tratament a crescut de la mai pu\u021bin de 10 paturi la peste 500 \u00een 19 centre de s\u0103n\u0103tate, \u00een timp ce capacitatea de testare s-a extins de la 30 de teste pe zi \u00een Kinshasa la peste 2.000 de teste zilnice \u00een nou\u0103 laboratoare din trei provincii.<\/p>\n<p id=\"p-11\">\u00cen ciuda progreselor, Tedros a avertizat c\u0103 focarul continu\u0103 s\u0103 dep\u0103\u0219easc\u0103 r\u0103spunsul pe fondul lipsei de finan\u021bare, incidentelor de securitate, urm\u0103ririi insuficient\u0103 a contactelor \u0219i accesului umanitar limitat.<\/p>\n<p id=\"p-12\">Focarul de Ebola, centrat \u00een provincia estic\u0103 Ituri, s-a r\u0103sp\u00e2ndit \u00een zonele \u00eenvecinate \u0219i a determinat o supraveghere sporit\u0103 \u00een Uganda, pe fondul preocup\u0103rilor legate de transmiterea transfrontalier\u0103.<\/p>\n<p id=\"p-13\">Oficialii din domeniul s\u0103n\u0103t\u0103\u021bii au avertizat c\u0103 focarul continu\u0103 s\u0103 reprezinte o amenin\u021bare regional\u0103 semnificativ\u0103, \u00een special \u00een zonele afectate de conflict, str\u0103mutarea popula\u021biei \u0219i infrastructura slab\u0103 de asisten\u021b\u0103 medical\u0103.<\/p>\n<p id=\"p-14\">Actualul focar este determinat de tulpina rar\u0103 Bundibugyo a virusului Ebola, pentru care nu exist\u0103 un vaccin aprobat. Boala provoac\u0103 febr\u0103 hemoragic\u0103 sever\u0103 \u0219i se r\u0103sp\u00e2nde\u0219te prin contact direct cu fluidele corporale infectate.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La o conferin\u021b\u0103 de pres\u0103 la Geneva, directorul general al OMS, Tedros Adhanom Ghebreyesus, a declarat c\u0103 preg\u0103tirile pentru studiu au fost finalizate. \u00cen cadrul studiului, se va evalua dac\u0103 &hellip; <a href=\"https:\/\/microscopemedia.com\/?p=699750\" class=\"more-link\">Read More<\/a><\/p>\n","protected":false},"author":1,"featured_media":699751,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"Default","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts\/699750"}],"collection":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=699750"}],"version-history":[{"count":0,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts\/699750\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/media\/699751"}],"wp:attachment":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=699750"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=699750"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=699750"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}